SCHEMBL439766

SCHEMBL439766

C[N+]1(CC(=O)O)CCOCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PABPC1 P11940 2/20 0.46
USP2 O75604 1/20 0.46
APOBEC3A P31941 5/20 0.44
APOBEC3G Q9HC16 5/20 0.44
CTDSP1 Q9GZU7 2/20 0.44
CYP2D6 P10635 1/20 0.44
GAA P10253 2/20 0.41
NPC1 O15118 1/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 1/20 0.41
RAD52 P43351 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
BBOX1 O75936 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
TERT O14746 7/20 0.35
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5092815 0.98 PABPC1 (0.45) PABPC1USP2APOBEC3AAPOBEC3GCTDSP1
SCHEMBL10532259 0.82 PABPC1 (0.46) PABPC1USP2APOBEC3AAPOBEC3GCTDSP1
SCHEMBL739514 0.80 PABPC1 (0.45) PABPC1USP2APOBEC3AAPOBEC3GCTDSP1
SCHEMBL9967918 0.80 PABPC1 (0.45) PABPC1USP2APOBEC3AAPOBEC3GCTDSP1
SCHEMBL3504706 0.78 BBOX1 (0.52) PABPC1USP2APOBEC3AAPOBEC3GCTDSP1
SCHEMBL170289 0.78 BBOX1 (0.56) PABPC1APOBEC3AAPOBEC3GCTDSP1MAPT
SCHEMBL12160892 0.77 APOBEC3A (0.50) PABPC1USP2APOBEC3AAPOBEC3GCTDSP1
SCHEMBL13051491 0.76 BBOX1 (0.39) CTDSP1SMN1; SMN2BBOX1
Hydrochloric Acid SCHEMBL5088036 0.76 BBOX1 (0.54) PABPC1APOBEC3AAPOBEC3GCTDSP1MAPT
SCHEMBL5087967 0.76 BBOX1 (0.54) PABPC1APOBEC3AAPOBEC3GCTDSP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116516433-B Green rapid preparation method of metal organic framework compound film coating 中国科学院深圳先进技术研究院 2024-04-26 CN claimed
CN-116516433-A Green rapid preparation method of metal organic framework compound film coating 中国科学院深圳先进技术研究院 2023-08-01 CN claimed
WO-2023138283-A1 ENVIRONMENTALLY FRIENDLY AND RAPID PREPARATION METHOD FOR METAL-ORGANIC FRAMEWORK COMPOUND THIN FILM PLATING 中国科学院深圳先进技术研究院 2023-07-27 WO claimed
CN-102702201-B Doripenem intermediate compound, preparation method and application of doripenem intermediate compound and preparation method for doripenem SHENZHEN HAIBIN PHARMACEUTICAL 2013-12-25 CN claimed
US-12584190-B2 Methods for selective recovery of rare earth elements and metals from coal ash by ionic liquids GEORGIA TECH RESEARCH CORPORATION (US) 2026-03-24 US disclosed
CN-116516433-B Green rapid preparation method of metal organic framework compound film coating 中国科学院深圳先进技术研究院 2024-04-26 CN disclosed
CN-117865961-A Improved preparation method of meropenem trihydrate 重庆圣华曦药业股份有限公司 2024-04-12 CN disclosed
US-20230357886-A1 Methods for Selective Recovery of Rare Earth Elements and Metals from Coal Ash by Ionic Liquids GEORGIA TECH RESEARCH CORPORATION 2023-11-09 US disclosed
CN-116516433-A Green rapid preparation method of metal organic framework compound film coating 中国科学院深圳先进技术研究院 2023-08-01 CN disclosed
WO-2023138283-A1 ENVIRONMENTALLY FRIENDLY AND RAPID PREPARATION METHOD FOR METAL-ORGANIC FRAMEWORK COMPOUND THIN FILM PLATING 中国科学院深圳先进技术研究院 2023-07-27 WO disclosed
EP-4077748-A1 METHODS FOR SELECTIVE RECOVERY OF RARE EARTH ELEMENTS AND METALS FROM COAL ASH BY IONIC LIQUIDS Georgia Tech Research Corporation (US) 2022-10-26 EP disclosed
US-20220205054-A1 QUANTITATIVE PROTEIN ANALYSIS SpectraFlora Group Pty Ltd (AU) 2022-06-30 US disclosed
EP-1556343-B1 PROCESS FOR THE PRODUCTION OF 3-METHYLTHIOPROPANAL ADISSEO IRELAND LTD (IE) 2007-08-29 EP disclosed
US-7256315-B2 Reacting methylmercaptan and acrolein in the presence of a catalyst of an acid and N-alkyl-morpholine ADISSEO IRELAND LTD. (IE) 2007-08-14 US disclosed
US-20070176992-A1 Ink composition and recording method FUJIFILM CORPORATION (JP) 2007-08-02 US disclosed
US-20050240048-A1 Process for the production of 3-methylthiopropanal ADISEO IRELAND LTD 2005-10-27 US disclosed
EP-1556343-A1 PROCESS FOR THE PRODUCTION OF 3-METHYLTHIOPROPANAL Adisseo Ireland Limited (IE) 2005-07-27 EP disclosed
WO-2004037774-A1 PROCESS FOR THE PRODUCTION OF 3-METHYLTHIOPROPANAL ADISSEO IRELAND LTD (IE) 2004-05-06 WO disclosed
EP-1413573-A1 Process for the production of 3-methylthiopropanal Adisseo France S.A.S. (FR) 2004-04-28 EP disclosed
US-20020019543-A1 Thiol derivative, metallo-beta-lactamase inhibitors BALKOVEC JAMES M (US) 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12584190-B2 Methods for selective recovery of rare earth elements and metals from coal ash by ionic liquids CA2, ASH2L, CA1 PABPC1 1704/4885USP2 3334/4885APOBEC3A 2657/4885
US-20020019543-A1 Thiol derivative, metallo-beta-lactamase inhibitors CBR1, LBR, CBR3 PABPC1 4634/4885USP2 2585/4885APOBEC3A 3492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.